Rituximab in the management of chronic immune thrombocytopenic purpura: what is its place?

Pediatr Blood Cancer. 2010 Apr;54(4):632. doi: 10.1002/pbc.22356.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / therapeutic use*
  • Chronic Disease
  • Combined Modality Therapy
  • Humans
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy*
  • Purpura, Thrombocytopenic, Idiopathic / surgery
  • Retrospective Studies
  • Rituximab
  • Splenectomy

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab